HK Stock MarketDetailed Quotes

01167 JACOBIO-B

Watchlist

1.290
-0.030-2.27%

Not Open Dec 20 16:08 CST

1.02BMarket Cap-2.56P/E (TTM)

JACOBIO-B Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Turnover

----

-33.66%63.52M

-26.24%40.34M

-37.34%95.75M

-5.20%54.69M

-68.58%152.81M

--57.69M

--486.29M

----

Operating income

-33.66%63.52M

-26.24%40.34M

-37.34%95.75M

-5.20%54.69M

-68.58%152.81M

57.69M

486.29M

Cost of sales

----

27.43%-60.32M

17.27%-37.93M

40.63%-83.11M

13.70%-45.85M

-217.30%-139.98M

---53.13M

---44.12M

----

Operating expenses

27.43%-60.32M

17.27%-37.93M

40.63%-83.11M

13.70%-45.85M

-217.30%-139.98M

-53.13M

-44.12M

Gross profit

-74.65%3.2M

-72.81%2.4M

-1.53%12.63M

93.88%8.83M

-97.10%12.83M

4.56M

442.17M

Administrative expenses

10.65%-21.19M

-9.55%-46.62M

-4.11%-23.72M

4.55%-42.55M

-22.94%-22.78M

17.20%-44.58M

-49.73%-18.53M

24.26%-53.84M

-80.64%-12.37M

-211.95%-71.08M

Research and development expenses

11.03%-176.83M

16.45%-372.32M

-12.55%-198.75M

-58.68%-445.65M

-45.15%-176.59M

-51.03%-280.84M

-71.32%-121.66M

-33.80%-185.95M

-31.19%-71.01M

-63.72%-138.98M

Special items of operating profit

-65.84%12.13M

-78.06%17.85M

-35.59%35.5M

1,296.87%81.36M

763.63%55.12M

70.79%-6.8M

-286.69%-8.31M

-246.47%-23.27M

26.75%4.45M

154.60%15.89M

Operating profit

-0.72%-185.89M

-0.93%-397.88M

-36.30%-184.56M

-23.43%-394.2M

5.92%-135.41M

-278.32%-319.38M

-82.35%-143.94M

192.24%179.11M

-37.36%-78.94M

-91.43%-194.17M

Financing income

0.08%22.07M

91.27%47.07M

185.85%22.05M

31.15%24.61M

0.93%7.72M

496.85%18.77M

317.48%7.64M

-41.04%3.14M

-38.72%1.83M

1,095.52%5.33M

Financing cost

-38.80%-5.23M

-266.17%-8.31M

-2,892.86%-3.77M

-299.65%-2.27M

58.42%-126K

62.06%-568K

57.86%-303K

-8.95%-1.5M

-17.87%-719K

32.75%-1.37M

Special items of earning before tax

----

-619.18%-1.69B

-633.34%-733.08M

-345.34%-235.61M

Earning before tax

-1.67%-169.05M

3.43%-359.12M

-30.08%-166.28M

-23.47%-371.86M

6.42%-127.83M

80.10%-301.19M

83.15%-136.6M

-255.48%-1.51B

-422.98%-810.9M

-173.07%-425.82M

After-tax profit from continuing operations

-1.67%-169.05M

3.43%-359.12M

-30.08%-166.28M

-23.47%-371.86M

6.42%-127.83M

80.10%-301.19M

83.15%-136.6M

-255.48%-1.51B

-422.98%-810.9M

-173.07%-425.82M

Earning after tax

-1.67%-169.05M

3.43%-359.12M

-30.08%-166.28M

-23.47%-371.86M

6.42%-127.83M

80.10%-301.19M

83.15%-136.6M

-255.48%-1.51B

-422.98%-810.9M

-173.07%-425.82M

Minority profit

----

97.81%-22K

99.15%-8K

85.04%-1.01M

Profit attributable to shareholders

-1.67%-169.05M

3.43%-359.12M

-30.08%-166.28M

-23.47%-371.86M

6.42%-127.83M

80.10%-301.19M

83.15%-136.6M

-256.31%-1.51B

-426.16%-810.9M

-184.70%-424.81M

Basic earnings per share

0.00%-0.22

6.12%-0.46

-29.41%-0.22

-22.50%-0.49

5.56%-0.17

89.92%-0.4

92.56%-0.18

-104.64%-3.97

31.25%-2.42

43.11%-1.94

Diluted earnings per share

0.00%-0.22

6.12%-0.46

-29.41%-0.22

-22.50%-0.49

5.56%-0.17

89.92%-0.4

92.56%-0.18

-104.64%-3.97

31.25%-2.42

43.11%-1.94

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

PricewaterhouseCoopers

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Turnover	----	-33.66%63.52M	-26.24%40.34M	-37.34%95.75M	-5.20%54.69M	-68.58%152.81M	--57.69M	--486.29M	----	----
Operating income		-33.66%63.52M	-26.24%40.34M	-37.34%95.75M	-5.20%54.69M	-68.58%152.81M	57.69M	486.29M
Cost of sales	----	27.43%-60.32M	17.27%-37.93M	40.63%-83.11M	13.70%-45.85M	-217.30%-139.98M	---53.13M	---44.12M	----	----
Operating expenses		27.43%-60.32M	17.27%-37.93M	40.63%-83.11M	13.70%-45.85M	-217.30%-139.98M	-53.13M	-44.12M
Gross profit		-74.65%3.2M	-72.81%2.4M	-1.53%12.63M	93.88%8.83M	-97.10%12.83M	4.56M	442.17M
Administrative expenses	10.65%-21.19M	-9.55%-46.62M	-4.11%-23.72M	4.55%-42.55M	-22.94%-22.78M	17.20%-44.58M	-49.73%-18.53M	24.26%-53.84M	-80.64%-12.37M	-211.95%-71.08M
Research and development expenses	11.03%-176.83M	16.45%-372.32M	-12.55%-198.75M	-58.68%-445.65M	-45.15%-176.59M	-51.03%-280.84M	-71.32%-121.66M	-33.80%-185.95M	-31.19%-71.01M	-63.72%-138.98M
Special items of operating profit	-65.84%12.13M	-78.06%17.85M	-35.59%35.5M	1,296.87%81.36M	763.63%55.12M	70.79%-6.8M	-286.69%-8.31M	-246.47%-23.27M	26.75%4.45M	154.60%15.89M
Operating profit	-0.72%-185.89M	-0.93%-397.88M	-36.30%-184.56M	-23.43%-394.2M	5.92%-135.41M	-278.32%-319.38M	-82.35%-143.94M	192.24%179.11M	-37.36%-78.94M	-91.43%-194.17M
Financing income	0.08%22.07M	91.27%47.07M	185.85%22.05M	31.15%24.61M	0.93%7.72M	496.85%18.77M	317.48%7.64M	-41.04%3.14M	-38.72%1.83M	1,095.52%5.33M
Financing cost	-38.80%-5.23M	-266.17%-8.31M	-2,892.86%-3.77M	-299.65%-2.27M	58.42%-126K	62.06%-568K	57.86%-303K	-8.95%-1.5M	-17.87%-719K	32.75%-1.37M
Special items of earning before tax	----	----	----	----	----	----	----	-619.18%-1.69B	-633.34%-733.08M	-345.34%-235.61M
Earning before tax	-1.67%-169.05M	3.43%-359.12M	-30.08%-166.28M	-23.47%-371.86M	6.42%-127.83M	80.10%-301.19M	83.15%-136.6M	-255.48%-1.51B	-422.98%-810.9M	-173.07%-425.82M
After-tax profit from continuing operations	-1.67%-169.05M	3.43%-359.12M	-30.08%-166.28M	-23.47%-371.86M	6.42%-127.83M	80.10%-301.19M	83.15%-136.6M	-255.48%-1.51B	-422.98%-810.9M	-173.07%-425.82M
Earning after tax	-1.67%-169.05M	3.43%-359.12M	-30.08%-166.28M	-23.47%-371.86M	6.42%-127.83M	80.10%-301.19M	83.15%-136.6M	-255.48%-1.51B	-422.98%-810.9M	-173.07%-425.82M
Minority profit	----	----	----	----	----	----	----	97.81%-22K	99.15%-8K	85.04%-1.01M
Profit attributable to shareholders	-1.67%-169.05M	3.43%-359.12M	-30.08%-166.28M	-23.47%-371.86M	6.42%-127.83M	80.10%-301.19M	83.15%-136.6M	-256.31%-1.51B	-426.16%-810.9M	-184.70%-424.81M
Basic earnings per share	0.00%-0.22	6.12%-0.46	-29.41%-0.22	-22.50%-0.49	5.56%-0.17	89.92%-0.4	92.56%-0.18	-104.64%-3.97	31.25%-2.42	43.11%-1.94
Diluted earnings per share	0.00%-0.22	6.12%-0.46	-29.41%-0.22	-22.50%-0.49	5.56%-0.17	89.92%-0.4	92.56%-0.18	-104.64%-3.97	31.25%-2.42	43.11%-1.94
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers	--	PricewaterhouseCoopers

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

Investment Theme

Pharmaceutical Companies

Intraday-0.05%

01167 JACOBIO-B

JACOBIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow